Information about Oncoradiomics
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0662.719.440

VAT liability
Yes
Established
19-09-2016
Last balance sheet year
2023
Company size
Medium-sized 26,7 FTE
Commercial name
Radiomics
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Oncoradiomics

2023 2022 2021 2020
Profit/Loss -1,902,176 20 % -2,367,092 -60 % -1,476,821 -105 % -720,356
Equity -3,614,843 -106 % -1,755,454 -528 % 410,086 183 % -494,411
Gross margin 876,905 182 % 311,341 -79 % 1,483,564 -8 % 1,611,375
Employees 26.7 28 23.4 14

Publications from Oncoradiomics

Date Publication
19-05-2025 Resignations, Appointments (FR)
03-01-2025 Miscellaneous (FR)
01-07-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares - Resignations, Appointments (FR)
05-01-2024 Resignations, Appointments (FR)
28-09-2022 Registered Office (FR)

Frequently asked questions

What is the VAT number of Oncoradiomics?
The VAT number of Oncoradiomics is BE 0662.719.440.
Wat is the PEPPOL ID of Oncoradiomics?
The PEPPOL ID of Oncoradiomics is 0208:0662719440. Log in or start a free trial to see the full overview.
When was Oncoradiomics founded?
Oncoradiomics was founded on 19-09-2016.
What is the address of Oncoradiomics?
The current registered office of Oncoradiomics is located at Boulevard de Patience et Beaujonc 3, 4000 Liège.
When was the last time Oncoradiomics filed their annual financial statements?
The most recent financial statements of Oncoradiomics were filed on 05-08-2024.
How many employees does Oncoradiomics have?
There are 26,7 FTEs working at Oncoradiomics according to the staff figures in the most recent financial statements.
What is the annual turnover of Oncoradiomics?
At the time of its most recent financial statements, Oncoradiomics did not publish any turnover figures. Oncoradiomics reported a gross margin of €876,905.00.